Cymbalta
formulated to manage major depressive disorder to support mental wellness.
Strengths: 20 · 30 · 40 · 60mg
Where to Check Availability
Medicine details
- Alternative names
Yentreve
- Therapeutic class
Serotonin-Norepinephrine Reuptake Inhibitor (SNRI)
- Pharmacological class
SNRI
- Contraindications
uncontrolled narrow-angle glaucoma; concurrent use of MAO inhibitors
- Precautions and warnings
monitor for suicidal ideation; may impair alertness
- Minor side effects
nausea; dry mouth
- Moderate side effects
insomnia; dizziness; somnolence
- Dosage forms
Prolonged-release capsule, hard
- Administration route
Oral use
- Patient summary
formulated to manage major depressive disorder to support mental wellness.
- Prescription status
POM
- Manufacturer
Eli Lilly
- Onset Time
1–2 weeks
- Duration
24 hours
- Storage instructions
Store below 25°C in a dry place.
- Drug interactions
alcohol; st. john's wort
- Pregnancy and breastfeeding
Pregnancy: consult specialist. Breastfeeding: discuss with physician.
Serious side effects
serotonin syndrome — requires immediate medical attention; hepatitis — requires immediate medical attention
Mechanism of action
it inhibits the neuronal uptake of serotonin and norepinephrine, resulting in increased levels of these neurotransmitters in the synaptic cleft.
Cymbalta
formulated to manage major depressive disorder to support mental wellness.
Editorial Notes
- Active ingredient(s): Duloxetine
- Listed indication(s): Major Depressive Disorder, Generalized Anxiety Disorder, Diabetic Peripheral Neuropathic Pain
Usually available as
- 120 tablets - 20 mg13-20-mg-2627
- 60 tablets - 30 mg13-30-mg-2631
- 60 tablets - 40 mg13-40-mg-2637